Why is Bandaram Pharma falling/rising?

As of 10-Oct, Bandaram Pharma Packtech Ltd is experiencing a decline in its stock price, currently at Rs 30.85, which reflects a decrease of Rs 0.22 or 0.71%. The stock has underperformed today, falling short of its sector performance by 0.27%. It is trading lower than all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 3.57% above Rs 29.75. Over the past year, the stock has generated a return of -37.05%, despite a 4% increase in profits, which is reflected in its high PEG ratio of 8.8. However, the company faces challenges with a high Debt to EBITDA ratio of 6.31 times, indicating a low ability to service debt, which contributes to its weak long-term fundamental strength. In the broader market context, Bandaram Pharma's short-term performance has been relatively better than the benchmark, with a 1-week return of +2.90% compared to the Sensex's +1.59%. However, the stock has significantly underperformed over the longer term, with a year-to-date return of -30.52% against the Sensex's +5.58%. This underperformance is compounded by a drastic fall in delivery volume, which has decreased by 99.68% against the 5-day average, suggesting a lack of investor interest. Overall, the combination of weak fundamentals, declining investor participation, and poor recent performance relative to the market contributes to the stock's downward movement.